{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06345755",
            "orgStudyIdInfo": {
                "id": "VX23-407-001"
            },
            "organization": {
                "fullName": "Vertex Pharmaceuticals Incorporated",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of VX-407 in Healthy Participants",
            "officialTitle": "A Phase 1, Randomized, Double-blind, Placebo-controlled, First-in-human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of VX-407 in Healthy Subjects",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "a-phase-study-to-evaluate-safety-tolerability-and-pharmacokinetics-pk-of-vx-in-healthy-participants"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-28",
            "studyFirstSubmitQcDate": "2024-03-28",
            "studyFirstPostDateStruct": {
                "date": "2024-04-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vertex Pharmaceuticals Incorporated",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetic parameters of VX-407 in healthy participants.",
            "detailedDescription": "This clinical trial information was submitted voluntarily under the applicable law and, therefore, certain submission deadlines may not apply. (That is, clinical trial information for this applicable clinical trial was submitted under section 402(j)(4)(A) of the Public Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.)."
        },
        "conditionsModule": {
            "conditions": [
                "Autosomal Dominant Polycystic Kidney Disease (ADPKD)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 95,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part A: Single Ascending Dose (SAD)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be randomized to receive a single dose of different dose levels of VX-407.",
                    "interventionNames": [
                        "Drug: VX-407"
                    ]
                },
                {
                    "label": "Part A: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will be randomized to receive placebo matched to VX-407.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Part B: Multiple Ascending Dose (MAD)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be randomized to receive multiple doses of different dose levels of VX-407. The dose levels will be determined based on the data from Part A.",
                    "interventionNames": [
                        "Drug: VX-407"
                    ]
                },
                {
                    "label": "Part B: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will be randomized to receive multiple doses of placebo matched to VX-407.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Part C (Optional): Drug-Drug Interaction",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be administered Midazolam (MDZ) in the presence or absence of VX-407. The dose levels will be determined based on the data from Part B.",
                    "interventionNames": [
                        "Drug: VX-407",
                        "Drug: Midazolam"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VX-407",
                    "description": "Solution or Suspension for oral administration.",
                    "armGroupLabels": [
                        "Part A: Single Ascending Dose (SAD)",
                        "Part B: Multiple Ascending Dose (MAD)",
                        "Part C (Optional): Drug-Drug Interaction"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Solution or Suspension for oral administration.",
                    "armGroupLabels": [
                        "Part A: Placebo",
                        "Part B: Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Midazolam",
                    "description": "Syrup for oral administration.",
                    "armGroupLabels": [
                        "Part C (Optional): Drug-Drug Interaction"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part A: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                    "timeFrame": "From Enrollment up to Day 10"
                },
                {
                    "measure": "Part B: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                    "timeFrame": "From Enrollment up to Day 23"
                },
                {
                    "measure": "Part C: Maximum Observed Plasma Concentration (Cmax) of MDZ in Absence and Presence of VX-407",
                    "timeFrame": "On Day 1, and Day 15"
                },
                {
                    "measure": "Part C: Area Under the Concentration Versus Time Curve (AUC) of MDZ in Absence and Presence of VX-407",
                    "timeFrame": "On Day 1, and Day 15"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Part A: Maximum Observed Plasma Concentration (Cmax) of VX-407",
                    "timeFrame": "From Day 1 up to Day 6"
                },
                {
                    "measure": "Part B: Maximum Observed Plasma Concentration (Cmax) of VX-407",
                    "timeFrame": "Days 1, 7, and 14"
                },
                {
                    "measure": "Part A: Area Under the Concentration Versus Time Curve (AUC) of VX-407",
                    "timeFrame": "From Day 1 up to Day 6"
                },
                {
                    "measure": "Part B: Area Under the Concentration Versus Time Curve (AUC) of VX-407",
                    "timeFrame": "Days 1, 7, and 14"
                },
                {
                    "measure": "Part C: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                    "timeFrame": "From Enrollment up to Day 24"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Body mass index (BMI) of 18.0 to 32.0 kilogram per meter square (kg/m\\^2)\n* A total body weight of greater than (\\>) 50 kg\n* Nonsmoker or ex-smoker for at least 3 months before screening\n\nKey Exclusion Criteria:\n\n* History of febrile illness or other acute illness that has not fully resolved within 14 days before the first dose of study drug\n* Any condition possibly affecting drug absorption\n\nOther protocol defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Medical Information",
                    "role": "CONTACT",
                    "phone": "617-341-6777",
                    "email": "medicalinfo@vrtx.com"
                }
            ],
            "locations": [
                {
                    "facility": "ICON Lenexa",
                    "status": "RECRUITING",
                    "city": "Lenexa",
                    "state": "Kansas",
                    "zip": "66219",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.95362,
                        "lon": -94.73357
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Details on Vertex data sharing criteria and process for requesting access can be found at: https://www.vrtx.com/independent-research/clinical-trial-data-sharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000007690",
                    "term": "Polycystic Kidney Diseases"
                },
                {
                    "id": "D000016891",
                    "term": "Polycystic Kidney, Autosomal Dominant"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000052177",
                    "term": "Kidney Diseases, Cystic"
                },
                {
                    "id": "D000000015",
                    "term": "Abnormalities, Multiple"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000072661",
                    "term": "Ciliopathies"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10712",
                    "name": "Polycystic Kidney Diseases",
                    "asFound": "Polycystic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19237",
                    "name": "Polycystic Kidney, Autosomal Dominant",
                    "asFound": "Autosomal Dominant Polycystic Kidney",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26983",
                    "name": "Kidney Diseases, Cystic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M14",
                    "name": "Abnormalities, Multiple",
                    "relevance": "LOW"
                },
                {
                    "id": "M1076",
                    "name": "Ciliopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T591",
                    "name": "Autosomal Dominant Multiple Pterygium Syndrome",
                    "asFound": "Autosomal Dominant",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008874",
                    "term": "Midazolam"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000759",
                    "term": "Adjuvants, Anesthesia"
                },
                {
                    "id": "D000006993",
                    "term": "Hypnotics and Sedatives"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000014151",
                    "term": "Anti-Anxiety Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018686",
                    "term": "Anesthetics, Intravenous"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000018757",
                    "term": "GABA Modulators"
                },
                {
                    "id": "D000018682",
                    "term": "GABA Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M11845",
                    "name": "Midazolam",
                    "asFound": "Course",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4089",
                    "name": "Adjuvants, Anesthesia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10043",
                    "name": "Hypnotics and Sedatives",
                    "relevance": "LOW"
                },
                {
                    "id": "M16905",
                    "name": "Anti-Anxiety Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M20766",
                    "name": "Anesthetics, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "relevance": "LOW"
                },
                {
                    "id": "M20827",
                    "name": "GABA Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AdjAn",
                    "name": "Adjuvants, Anesthesia"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                }
            ]
        }
    },
    "hasResults": false
}